Viral Vaccines Market Size, Share & Industry Analysis, By Form (Liquid and Lyophilized), By Container Format (Vials and Prefilled Syringes), By Biosafety Level Type (Biosafety Level 1, Biosafety Level 2, Biosafety Level 3, and Biosafety Level 4), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI107531

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, By Key Players
2. Key Industry Developments: Mergers, Acquisitions, and Partnerships
3. Epidemiology: Key Viral Diseases, By Key Countries, 2025
4. Pipeline Analysis, By Key Players
5. Impact of COVID-19 on the Market
Global Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Rest of Asia Pacific
Rest of the World Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Merck & Co., Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. GSK plc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Sanofi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. SEQIRUS (CSL Limited)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Moderna, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Novavax
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Dynavax Technologies
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, By Key Players
2. Key Industry Developments: Mergers, Acquisitions, and Partnerships
3. Epidemiology: Key Viral Diseases, By Key Countries, 2025
4. Pipeline Analysis, By Key Players
5. Impact of COVID-19 on the Market
Global Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Rest of Asia Pacific
Rest of the World Viral Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Form
  1. Liquid
  2. Lyophilized
2. Market Analysis, Insights and Forecast – By Container Format
  1. Vials
  2. Prefilled Syringes
3. Market Analysis, Insights and Forecast – By Biosafety Level Type
  1. Biosafety Level 1
  2. Biosafety Level 2
  3. Biosafety Level 3
  4. Biosafety Level 4
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Merck & Co., Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. GSK plc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Sanofi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. SEQIRUS (CSL Limited)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Moderna, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Novavax
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Dynavax Technologies
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Viral Vaccines Market Value Share (%), By Form, 2025 & 2034

Figure 2: Global Viral Vaccines Market Value Share (%), By Container Format, 2025 & 2034

Figure 3: Global Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2025 & 2034

Figure 4: Global Viral Vaccines Market Value Share (%), By Region, 2025 & 2034

Figure 5: North America Viral Vaccines Market Value (USD billion), by Form, 2025 & 2034

Figure 6: North America Viral Vaccines Market Value Share (%), by Form, 2025

Figure 7: North America Viral Vaccines Market Value (USD billion), by Container Format, 2025 & 2034

Figure 8: North America Viral Vaccines Market Value Share (%), by Container Format, 2025

Figure 9: North America Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2025 & 2034

Figure 10: North America Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2025

Figure 11: North America Viral Vaccines Market Value (USD billion), by Country, 2025 & 2034

Figure 12: North America Viral Vaccines Market Value Share (%), by Country, 2025

Figure 13: Europe Viral Vaccines Market Value (USD billion), by Form, 2025 & 2034

Figure 14: Europe Viral Vaccines Market Value Share (%), by Form, 2025

Figure 15: Europe Viral Vaccines Market Value (USD billion), by Container Format, 2025 & 2034

Figure 16: Europe Viral Vaccines Market Value Share (%), by Container Format, 2025

Figure 17: Europe Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2025 & 2034

Figure 18: Europe Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2025

Figure 19: Europe Viral Vaccines Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 20: Europe Viral Vaccines Market Value Share (%), by Country/ Sub-Region, 2025

Figure 21: Asia Pacific Viral Vaccines Market Value (USD billion), by Form, 2025 & 2034

Figure 22: Asia Pacific Viral Vaccines Market Value Share (%), by Form, 2025

Figure 23: Asia Pacific Viral Vaccines Market Value (USD billion), by Container Format, 2025 & 2034

Figure 24: Asia Pacific Viral Vaccines Market Value Share (%), by Container Format, 2025

Figure 25: Asia Pacific Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2025 & 2034

Figure 26: Asia Pacific Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2025

Figure 27: Asia Pacific Viral Vaccines Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 28: Asia Pacific Viral Vaccines Market Value Share (%), by Country/ Sub-Region, 2025

Figure 29: Rest of the World Viral Vaccines Market Value (USD billion), by Form, 2025 & 2034

Figure 30: Rest of the World Viral Vaccines Market Value Share (%), by Form, 2025

Figure 31: Rest of the World Viral Vaccines Market Value (USD billion), by Container Format, 2025 & 2034

Figure 32: Rest of the World Viral Vaccines Market Value Share (%), by Container Format, 2025

Figure 33: Rest of the World Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2025 & 2034

Figure 34: Rest of the World Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2025

Figure 35: Global Viral Vaccines Market Share (%), By Company, 2025

List of Tables

Table 1: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2021-2034

Table 2: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2021-2034

Table 3: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2021–2034

Table 4: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 5: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2021-2034

Table 6: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2021-2034

Table 7: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2021–2034

Table 8: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2021-2034

Table 10: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2021-2034

Table 11: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2021–2034

Table 12: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 13: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2021-2034

Table 14: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2021-2034

Table 15: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2021–2034

Table 16: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 17: Rest of the World Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2021-2034

Table 18: Rest of the World Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2021-2034

Table 19: Rest of the World Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 124

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com